Latest News
Quidel's QuickVue At-Home OTC COVID-19 Test Now Available for Sale Through Amazon
14 May 2021 - - US-based rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems provider Quidel Corp's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test is now available in ...
Osmol Therapeutics Initiates IND Enabling Studies to Develop First Therapy for Prevention of Chemotherapy-Induced Peripheral Neuropathy
14 May 2021 - - US-based biopharma company Osmol Therapeutics has initiated Investigational New Drug enabling studies to develop a therapy to prevent chemotherapy-induced peripheral neuropathy, the company said.

A phase 1 clinical study ...
Porfido Named Chief Financial Officer at Tyme
14 May 2021 - - US-based biotechnology company Tyme Technologies, Inc. (NASDAQ: TYME) has appointed Frank L. Porfido as its chief financial officer, effective shortly after the company files its annual report on form 10-K, the company said.
Gemini Therapeutics Completes Enrollment in Phase 2a Study of GEM103 as an Add-On to Anti-VEGF Therapy for the Treatment of Wet AMD Patients at Risk for Progressive Vision Loss Due to Macular Atrophy
14 May 2021 - - US-based precision medicine company Gemini Therapeutics, Inc. (NASDAQ: GMTX) has completed enrollment in its Phase 2a trial advancing GEM103 as a potential add-on therapy for patients suffering from wet AMD and requiring continued ant...
Flare Therapeutics Launches with USD 82m series A Financing to Advance Precision Oncology Pipeline
14 May 2021 - - US-based biotechnology company Flare Therapeutics launched with a series A financing of USD 82m, the company said.

The series A was led by Third Rock Ventures with significant support by Boxer Capital, Nextech Invest, Cas...